Skip to content

Clinical trials

Terminated Smoldering Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Smoldering Multiple Myeloma Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20094
20102
20111
20131
20172
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Barbara Ann Karmanos Cancer Institute1
BioInvent International AB1
Icahn School of Medicine at Mount Sinai1
Lene Meldgaard Knudsen1
Marshall University1
Mayo Clinic1
NYU Langone Health1
Rennes University Hospital1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Smoldering Multiple Myeloma13
Multiple Myeloma7
Neoplasms, Plasma Cell7
Monoclonal Gammopathy of Undetermined Significance4
Leukemia, Lymphocytic, Chronic, B-Cell1
Neoplasms1
Precancerous Conditions1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.